Literature DB >> 17636030

Amino acid residues required for physical and cooperative transcriptional interaction of STAT3 and AP-1 proteins c-Jun and c-Fos.

Michael Ginsberg1, Elmar Czeko, Patrick Müller, Zhiyong Ren, Xiaomin Chen, James E Darnell.   

Abstract

Cooperation between STAT3 and c-Jun in driving transcription during transfection of reporter constructs is well established, and both proteins are present on some interleukin-6 (IL-6) STAT3-dependent promoters on chromosomal loci. We report that small interfering RNA knockdown of c-Jun or c-Fos diminishes IL-6 induction of some but not all STAT3-dependent mRNAs. Specific contact sites in STAT3 responsible for interaction of a domain of STAT3 with c-Jun were known. Here we show that the B-zip domain of c-Jun interacts with STAT3 and that c-Jun mutation R261A or R261D near but not in the DNA binding domain blocks in vitro STAT3-c-Jun interaction and decreases costimulation of transcription in transfection assays. Cooperative binding to DNA of tyrosine-phosphorylated STAT3 and both wild-type and R261A mutant c-Jun was observed. Even c-Jun mutant R261D, which on its own did not bind DNA, bound DNA weakly in the presence of STAT3. We conclude that a functional interaction between STAT3 and c-Jun while bound to chromosomal DNA elements exists and is necessary for driving transcription on at least some STAT3 target genes. Identifying such required interactive protein interfaces should be a stimulus to search for compounds that could ultimately inhibit the activity of STAT3 in tumors dependent on persistently active STAT3.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17636030      PMCID: PMC2099614          DOI: 10.1128/MCB.00613-07

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  32 in total

Review 1.  Transcription factors as targets for cancer therapy.

Authors:  James E Darnell
Journal:  Nat Rev Cancer       Date:  2002-10       Impact factor: 60.716

Review 2.  Stats: transcriptional control and biological impact.

Authors:  David E Levy; J E Darnell
Journal:  Nat Rev Mol Cell Biol       Date:  2002-09       Impact factor: 94.444

3.  Synergistic activity of STAT3 and c-Jun at a specific array of DNA elements in the alpha 2-macroglobulin promoter.

Authors:  J Y Yoo; W Wang; S Desiderio; D Nathans
Journal:  J Biol Chem       Date:  2001-04-23       Impact factor: 5.157

Review 4.  Jun, the oncoprotein.

Authors:  P K Vogt
Journal:  Oncogene       Date:  2001-04-30       Impact factor: 9.867

Review 5.  Small molecule inhibitors of Stat3 signaling pathway.

Authors:  Jinxia Deng; Fedora Grande; Nouri Neamati
Journal:  Curr Cancer Drug Targets       Date:  2007-02       Impact factor: 3.428

6.  Small-molecule antagonists of Myc/Max dimerization inhibit Myc-induced transformation of chicken embryo fibroblasts.

Authors:  Thorsten Berg; Steven B Cohen; Joel Desharnais; Corinna Sonderegger; Daniel J Maslyar; Joel Goldberg; Dale L Boger; Peter K Vogt
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-12       Impact factor: 11.205

7.  JNK phosphorylation relieves HDAC3-dependent suppression of the transcriptional activity of c-Jun.

Authors:  Carsten Weiss; Sandra Schneider; Erwin F Wagner; Xiaohong Zhang; Edward Seto; Dirk Bohmann
Journal:  EMBO J       Date:  2003-07-15       Impact factor: 11.598

8.  Low molecular weight inhibitors of Myc-Max interaction and function.

Authors:  Xiaoying Yin; Christine Giap; John S Lazo; Edward V Prochownik
Journal:  Oncogene       Date:  2003-09-18       Impact factor: 9.867

Review 9.  Targeting transcription factors for cancer gene therapy.

Authors:  Towia A Libermann; Luiz F Zerbini
Journal:  Curr Gene Ther       Date:  2006-02       Impact factor: 4.391

10.  STAT3-dependent enhanceosome assembly and disassembly: synergy with GR for full transcriptional increase of the alpha 2-macroglobulin gene.

Authors:  Lorena Lerner; Melissa A Henriksen; Xiaokui Zhang; James E Darnell
Journal:  Genes Dev       Date:  2003-10-01       Impact factor: 11.361

View more
  17 in total

1.  Mutations in the linker domain affect phospho-STAT3 function and suggest targets for interrupting STAT3 activity.

Authors:  Claudia Mertens; Bhagwattie Haripal; Sebastian Klinge; James E Darnell
Journal:  Proc Natl Acad Sci U S A       Date:  2015-11-09       Impact factor: 11.205

2.  Epitope tagging of endogenous proteins for genome-wide ChIP-chip studies.

Authors:  Xiaodong Zhang; Chunguang Guo; Yueting Chen; Hennady P Shulha; Michael P Schnetz; Thomas LaFramboise; Cynthia F Bartels; Sanford Markowitz; Zhiping Weng; Peter C Scacheri; Zhenghe Wang
Journal:  Nat Methods       Date:  2008-01-06       Impact factor: 28.547

Review 3.  Complex interactions of transcription factors in mediating cytokine biology in T cells.

Authors:  Peng Li; Rosanne Spolski; Wei Liao; Warren J Leonard
Journal:  Immunol Rev       Date:  2014-09       Impact factor: 12.988

4.  STAT3 mediates resistance to MEK inhibitor through microRNA miR-17.

Authors:  Bingbing Dai; Jieru Meng; Michael Peyton; Luc Girard; William G Bornmann; Lin Ji; John D Minna; Bingliang Fang; Jack A Roth
Journal:  Cancer Res       Date:  2011-03-28       Impact factor: 12.701

5.  Signal transducer and activator of transcription 3 and 5 regulate system Xc- and redox balance in human breast cancer cells.

Authors:  Katja Linher-Melville; Sina Haftchenary; Patrick Gunning; Gurmit Singh
Journal:  Mol Cell Biochem       Date:  2015-04-21       Impact factor: 3.396

6.  Protein kinase C epsilon regulation of translocator protein (18 kDa) Tspo gene expression is mediated through a MAPK pathway targeting STAT3 and c-Jun transcription factors.

Authors:  Amani Batarseh; Jiehan Li; Vassilios Papadopoulos
Journal:  Biochemistry       Date:  2010-06-15       Impact factor: 3.162

7.  MUC16 induced rapid G2/M transition via interactions with JAK2 for increased proliferation and anti-apoptosis in breast cancer cells.

Authors:  I Lakshmanan; M P Ponnusamy; S Das; S Chakraborty; D Haridas; P Mukhopadhyay; S M Lele; S K Batra
Journal:  Oncogene       Date:  2011-07-25       Impact factor: 9.867

8.  STAT3 mutations correlated with hyper-IgE syndrome lead to blockage of IL-6/STAT3 signalling pathway.

Authors:  Jianxin He; Jie Shi; Ximing Xu; Wenhua Zhang; Yuxin Wang; Xing Chen; Yuping Du; Ning Zhu; Jing Zhang; Qin Wang; Jinbo Yang
Journal:  J Biosci       Date:  2012-06       Impact factor: 1.826

9.  JAK-STAT1/3-induced expression of signal sequence-encoding proopiomelanocortin mRNA in lymphocytes reduces inflammatory pain in rats.

Authors:  Melanie Busch-Dienstfertig; Dominika Labuz; Theresa Wolfram; Nicole N Vogel; Christoph Stein
Journal:  Mol Pain       Date:  2012-11-13       Impact factor: 3.395

10.  Signal transducer and activator of transcription 3 activation up-regulates interleukin-6 autocrine production: a biochemical and genetic study of established cancer cell lines and clinical isolated human cancer cells.

Authors:  Wei-Lun Huang; Hsuan-Heng Yeh; Chien-Chung Lin; Wu-Wei Lai; Jang-Yang Chang; Wen-Tsan Chang; Wu-Chou Su
Journal:  Mol Cancer       Date:  2010-12-02       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.